Log in or Sign up for Free to view tailored content for your specialty!
Dermatitis News
Consider sharing action plan with patients to help them manage eczema
MIAMI BEACH, Fla. — Clinicians should consider implementing an action plan for eczema treatment to maximize patient education, according to a presentation at the Masters of Pediatric Dermatology meeting.
‘With great power comes great responsibility’: Boxed warnings in pediatric dermatology
MIAMI BEACH, Fla. — Pediatric dermatologists should be open with patients and families when discussing boxed warnings while emphasizing that the benefits outweigh the risks, according to a speaker here.
Log in or Sign up for Free to view tailored content for your specialty!
VIDEO: Upadacitinib could produce ‘rapid’ improvement in atopic dermatitis
In this video, Raj Chovatiya, MD, PhD, discussed research into the Janus kinase inhibitor upadacitinib from the Maui Derm 2024 meeting, examining data into its use in treating atopic dermatitis.
VIDEO: ‘No new safety events’ for abrocitinib in atopic dermatitis
In this Healio exclusive video, Raj Chovatiya, MD, PhD, discussed research into the Janus kinase 1 inhibitor abrocitinib from the Maui Derm 2024 meeting, examining data into its use in treating atopic dermatitis.
JAK inhibitors have ‘untapped potential’ in treatment of inflammatory skin diseases
MIAMI BEACH, Fla. — Janus kinase inhibitors have a unique mechanism of action, giving them the potential to push the boundaries of efficacy in the treatment of inflammatory skin diseases, according to a speaker at South Beach Symposium.
VIDEO: Dupilumab effective for childhood, hand, foot atopic dermatitis
In this Healio exclusive video, Raj Chovatiya, MD, PhD, discussed research into the interleukin-4 alpha blocker dupilumab from the Maui Derm 2024 meeting, particularly its use in childhood and hand and foot atopic dermatitis.
VIDEO: Tralokinumab shows long-term improvement in atopic dermatitis
In this Healio exclusive video, Raj Chovatiya, MD, PhD, discussed research into the interleukin-13 blocker tralokinumab from the Maui Derm 2024 meeting, centering around research into longer-term use of the treatment for atopic dermatitis.
Roflumilast foam outperforms vehicle in seborrheic dermatitis treatment
Phase 3 results that supported the approval of roflumilast foam 0.3% for seborrheic dermatitis treatment showed that the drug was superior to vehicle for individuals aged 9 years and older in this indication, according to a study.
Mount Sinai partners with Clinique to open center for dermatitis, aging research
Icahn School of Medicine at Mount Sinai and Clinique have partnered to establish the Mount Sinai-Clinique Healthy Skin Dermatology Center, Mount Sinai announced in a press release.
South Beach Symposium adds ‘unique session’ focused on holistic dermatologic treatment
In addition to cutting edge content, the 22nd annual South Beach Symposium has added a “unique session” that focuses on how the medical and cosmetic dermatologist can work together to holistically treat patients.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read